NCT01111604 2019-08-06A Study of Ramucirumab or Icrucumab in Colorectal CancerEli Lilly and CompanyPhase 2 Completed158 enrolled 17 charts
NCT01286818 2014-10-06A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)Eli Lilly and CompanyPhase 1 Completed6 enrolled 12 charts